Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF

ClinicalTrials.gov ID: NCT03538301

Public ClinicalTrials.gov record NCT03538301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Study identification

NCT ID
NCT03538301
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Nitto Denko Corporation
Industry
Enrollment
123 participants

Conditions and interventions

Interventions

  • ND-L02-s0201 (Low Dose) Drug
  • ND-L02-s0201 (High Dose) Drug
  • Other: Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2018
Primary completion
Aug 23, 2022
Completion
Aug 23, 2022
Last update posted
Dec 10, 2023

2018 – 2022

United States locations

U.S. sites
21
U.S. states
15
U.S. cities
21
Facility City State ZIP Site status
Banner-University Medical Center Tucson Campus Tucson Arizona 85724-0001
Cedars-Sinai Medical Center Los Angeles California 90048
Amicis Research Center Northridge California 91324
University of California, San Francisco, Medical Center at Parnassus San Francisco California 94143
Mayo Clinic Florida Jacksonville Florida 32224
Central Florida Pulmonary Group, PA Orlando Florida 32803
Emory University Atlanta Georgia 30322
Loyola University Medical Center Maywood Illinois 60153
OSF HealthCare Saint Francis Medical Center Peoria Illinois 61637
Norton Clinical Research Group Louisville Kentucky 40218
Massachusetts General Hospital Boston Massachusetts 02114
University of Minnesota Medical School Minneapolis Minnesota 55455
Dartmouth-Hitchcock Medical Center (DHMC) Lebanon New Hampshire 03756
Duke University Hospital Durham North Carolina 27708
Penn State Hershey Medical Center Hershey Pennsylvania 17033
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
UT Southwestern Medical Center Dallas Texas 75390
UT Health San Antonio: First Outpatient Research Unit San Antonio Texas 78229
University of Utah Health Salt Lake City Utah 84108
University of Washington Seattle Washington 98195-0001

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03538301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03538301 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →